Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis

Leslie G. Cleland, Gillian Caughey, Michael J. James, Susanna M. Proudmam

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Objective. Rheumatoid arthritis (RA) is associated with increased risk for cardiovascular (CV) events through multiple factors. Fish oil has been shown to reduce symptoms in RA and to reduce CV risk. We assessed the effect of an antiinflammatory dose of fish oil on CV risk factors within a program of combination chemotherapy for patients with early RA. Methods. Patients who chose not to take fish oil (n = 13) were compared with patients who achieved a sustained elevation of eicosapentaenoic acid (EPA) in plasma phospholipid fatty acids (> 5% total fatty acids) while taking fish oil over a 3-year period (n = 18). We examined cellular content of arachidonic acid (AA), synthesis of thromboxane A2 and prostaglandin E2, use of nonsteroidal antiinflammatory drugs (NSAID). traditional CV lipid risk factors, and disease activity at 3 years. Results. At 3 years, AA (as a proportion of AA plus long-chain n-3 fatty acids that can compete with AA for cyclooxygenase metabolism) was 30% lower in platelets and 40% lower in peripheral blood mononuclear cells in subjects taking fish oil. Serum thromboxane B2 was 35% lower and lipopolysaccharide-stimulated whole-blood prostaglandin E 2 was 41% lower with fish oil ingestion compared to no fish oil. NSAID use was reduced by 75% from baseline with fish oil (p < 0.05) and by 37% without fish oil (NS). Favorable changes in fasting blood lipids were seen with, but not without fish oil. Remission at 3 years was more frequent with fish oil use (72%) compared to no fish oil (31%). Conclusion. Fish oil reduces cardiovascular risk in patients with RA through multiple mechanisms.

LanguageEnglish
Pages1973-1979
Number of pages7
JournalJournal of Rheumatology
Volume33
Issue number10
Publication statusPublished - 1 Oct 2006
Externally publishedYes

Keywords

  • Cardiovascular risk
  • Combination therapy
  • Cyclooxygenase inhibition
  • Early rheumatoid arthritis
  • Fish oil
  • Remission

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

Cleland, Leslie G. ; Caughey, Gillian ; James, Michael J. ; Proudmam, Susanna M. / Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. In: Journal of Rheumatology. 2006 ; Vol. 33, No. 10. pp. 1973-1979.
@article{b0ec5da4a7af43c7bb0558f9b91a4184,
title = "Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis",
abstract = "Objective. Rheumatoid arthritis (RA) is associated with increased risk for cardiovascular (CV) events through multiple factors. Fish oil has been shown to reduce symptoms in RA and to reduce CV risk. We assessed the effect of an antiinflammatory dose of fish oil on CV risk factors within a program of combination chemotherapy for patients with early RA. Methods. Patients who chose not to take fish oil (n = 13) were compared with patients who achieved a sustained elevation of eicosapentaenoic acid (EPA) in plasma phospholipid fatty acids (> 5{\%} total fatty acids) while taking fish oil over a 3-year period (n = 18). We examined cellular content of arachidonic acid (AA), synthesis of thromboxane A2 and prostaglandin E2, use of nonsteroidal antiinflammatory drugs (NSAID). traditional CV lipid risk factors, and disease activity at 3 years. Results. At 3 years, AA (as a proportion of AA plus long-chain n-3 fatty acids that can compete with AA for cyclooxygenase metabolism) was 30{\%} lower in platelets and 40{\%} lower in peripheral blood mononuclear cells in subjects taking fish oil. Serum thromboxane B2 was 35{\%} lower and lipopolysaccharide-stimulated whole-blood prostaglandin E 2 was 41{\%} lower with fish oil ingestion compared to no fish oil. NSAID use was reduced by 75{\%} from baseline with fish oil (p < 0.05) and by 37{\%} without fish oil (NS). Favorable changes in fasting blood lipids were seen with, but not without fish oil. Remission at 3 years was more frequent with fish oil use (72{\%}) compared to no fish oil (31{\%}). Conclusion. Fish oil reduces cardiovascular risk in patients with RA through multiple mechanisms.",
keywords = "Cardiovascular risk, Combination therapy, Cyclooxygenase inhibition, Early rheumatoid arthritis, Fish oil, Remission",
author = "Cleland, {Leslie G.} and Gillian Caughey and James, {Michael J.} and Proudmam, {Susanna M.}",
year = "2006",
month = "10",
day = "1",
language = "English",
volume = "33",
pages = "1973--1979",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "10",

}

Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. / Cleland, Leslie G.; Caughey, Gillian; James, Michael J.; Proudmam, Susanna M.

In: Journal of Rheumatology, Vol. 33, No. 10, 01.10.2006, p. 1973-1979.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis

AU - Cleland, Leslie G.

AU - Caughey, Gillian

AU - James, Michael J.

AU - Proudmam, Susanna M.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Objective. Rheumatoid arthritis (RA) is associated with increased risk for cardiovascular (CV) events through multiple factors. Fish oil has been shown to reduce symptoms in RA and to reduce CV risk. We assessed the effect of an antiinflammatory dose of fish oil on CV risk factors within a program of combination chemotherapy for patients with early RA. Methods. Patients who chose not to take fish oil (n = 13) were compared with patients who achieved a sustained elevation of eicosapentaenoic acid (EPA) in plasma phospholipid fatty acids (> 5% total fatty acids) while taking fish oil over a 3-year period (n = 18). We examined cellular content of arachidonic acid (AA), synthesis of thromboxane A2 and prostaglandin E2, use of nonsteroidal antiinflammatory drugs (NSAID). traditional CV lipid risk factors, and disease activity at 3 years. Results. At 3 years, AA (as a proportion of AA plus long-chain n-3 fatty acids that can compete with AA for cyclooxygenase metabolism) was 30% lower in platelets and 40% lower in peripheral blood mononuclear cells in subjects taking fish oil. Serum thromboxane B2 was 35% lower and lipopolysaccharide-stimulated whole-blood prostaglandin E 2 was 41% lower with fish oil ingestion compared to no fish oil. NSAID use was reduced by 75% from baseline with fish oil (p < 0.05) and by 37% without fish oil (NS). Favorable changes in fasting blood lipids were seen with, but not without fish oil. Remission at 3 years was more frequent with fish oil use (72%) compared to no fish oil (31%). Conclusion. Fish oil reduces cardiovascular risk in patients with RA through multiple mechanisms.

AB - Objective. Rheumatoid arthritis (RA) is associated with increased risk for cardiovascular (CV) events through multiple factors. Fish oil has been shown to reduce symptoms in RA and to reduce CV risk. We assessed the effect of an antiinflammatory dose of fish oil on CV risk factors within a program of combination chemotherapy for patients with early RA. Methods. Patients who chose not to take fish oil (n = 13) were compared with patients who achieved a sustained elevation of eicosapentaenoic acid (EPA) in plasma phospholipid fatty acids (> 5% total fatty acids) while taking fish oil over a 3-year period (n = 18). We examined cellular content of arachidonic acid (AA), synthesis of thromboxane A2 and prostaglandin E2, use of nonsteroidal antiinflammatory drugs (NSAID). traditional CV lipid risk factors, and disease activity at 3 years. Results. At 3 years, AA (as a proportion of AA plus long-chain n-3 fatty acids that can compete with AA for cyclooxygenase metabolism) was 30% lower in platelets and 40% lower in peripheral blood mononuclear cells in subjects taking fish oil. Serum thromboxane B2 was 35% lower and lipopolysaccharide-stimulated whole-blood prostaglandin E 2 was 41% lower with fish oil ingestion compared to no fish oil. NSAID use was reduced by 75% from baseline with fish oil (p < 0.05) and by 37% without fish oil (NS). Favorable changes in fasting blood lipids were seen with, but not without fish oil. Remission at 3 years was more frequent with fish oil use (72%) compared to no fish oil (31%). Conclusion. Fish oil reduces cardiovascular risk in patients with RA through multiple mechanisms.

KW - Cardiovascular risk

KW - Combination therapy

KW - Cyclooxygenase inhibition

KW - Early rheumatoid arthritis

KW - Fish oil

KW - Remission

UR - http://www.scopus.com/inward/record.url?scp=33750016798&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 1973

EP - 1979

JO - Journal of Rheumatology

T2 - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 10

ER -